Skip to main content

Models of patient engagement for Alzheimer’s disease


Start Date
End Date
Total Funding
€ 4 591 968
Funding Programme
European Countries Involved

Dementia researchers are increasingly focusing their efforts on finding ways to prevent the onset of dementia symptoms in the first place, and for this they need to work with people who are still in the very earliest stages of the disease. The MOPEAD project aims to identify and test different models for engaging with this important group and determine which models work best in different situations. As well as adding to our understanding of the earliest stages of dementia, the project will facilitate recruitment for clinical trials and, most importantly, ensure that patients are able to access support from early on in their disease.

Project partners

Fundacio Ace

Eli Lilly And Company Limited

Asdm Consulting

Astrazeneca Ab

European Institute Of Women'S Health Company Limited By Guarantee

Gmv Soluciones Globales Internet Sau

Karolinska Institutet

Kite Innovation (Europe)

Spomincica Alzheimer Slovenija Slovensko Zdruzenje Za Pomoc Pri Demenci

Klinikum Der Universitaet Zu Koeln

Univerzitetni Klinicni

Center Ljubljana

Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca tichting Vumc

Alzheimer Europe

Modus Research And Innovation Limited

Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).